Active maintenance of endothelial cells prevents kidney fibrosis
Kidney Research and Clinical Practice
; : 329-341, 2017.
Article
de En
| WPRIM
| ID: wpr-143311
Bibliothèque responsable:
WPRO
ABSTRACT
BACKGROUND: Soluble epoxide hydrolase (sEH) expressed by endothelial cells catalyzes the metabolism of epoxyeicosatrienoic acids (EETs), which are vasoactive agents. METHODS: We used a unilateral ureteral obstruction mouse model of kidney fibrosis to determine whether inhibition of sEH activity reduces fibrosis, the final common pathway for chronic kidney disease. RESULTS: sEH activity was inhibited by continuous release of the inhibitor 12-(3-adamantan-1-ylureido)-dodecanoic acid (AUDA) for 1 or 2 weeks. Treatment with AUDA significantly ameliorated tubulointerstitial fibrosis by reducing fibroblast mobilization and enhancing endothelial cell activity. In an in vitro model of endothelial-to-mesenchymal transition (EndMT) using human vascular endothelial cells (HUVECs), AUDA prevented the morphologic changes associated with EndMT and reduced expression of fibroblast-specific protein 1. Furthermore, HUVECs activated by AUDA prevented the epithelial-to-mesenchymal transition (EMT) of tubular epithelial cells in a co-culture system. CONCLUSION: Our findings suggest that regulation of sEH is a potential target for therapies aimed at delaying the progression of kidney fibrosis by inhibiting EndMT and EMT.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Obstruction urétérale
/
Techniques in vitro
/
Fibrose
/
Techniques de coculture
/
Cellules endothéliales
/
Cellules épithéliales
/
Insuffisance rénale chronique
/
Transition épithélio-mésenchymateuse
/
Fibroblastes
/
Rein
Limites du sujet:
Animals
/
Humans
langue:
En
Texte intégral:
Kidney Research and Clinical Practice
Année:
2017
Type:
Article